RETRACTION: A Randomized, Participant- and Evaluator-Blinded, Matched-Pair, Prospective Study Comparing the Safety and Efficacy Between Polycaprolactone and Polynucleotide Fillers in the Correction of Crow's Feet.
Abstract
S. Y. Choi, Y. G. Koh, K. H. Yoo, H. S. Han, J. Seok, and B. J. Kim, "A Randomized, Participant- and Evaluator-Blinded, Matched-Pair, Prospective Study Comparing the Safety and Efficacy Between Polycaprolactone and Polynucleotide Fillers in the Correction of Crow's Feet," Journal of Cosmetic Dermatology 24, no. 1 (2025): e16576, https://doi.org/10.1111/jocd.16576. The above article, published online on 23 September 2024 in Wiley Online Library (wileyonlinelibrary.com) has been retracted by agreement between the authors; the journal Editor-in-Chief, Michael H Gold; and Wiley Periodicals, LLC. The retraction has been agreed following the authors' request. The authors informed the journal that a misidentification occurred regarding the dermal filler used in the clinical study. Specifically, the product DLMRO1 dermal filler was misidentified as containing pegylated polycaprolactone (PCL), whereas it is composed solely of pure PCL filler. Because pure PCL and pegylated PCL are distinct materials with different biocompatibility, viscosity, and biodegradation profiles, the misidentification significantly affects the reported methods and undermines the reliability of the study's findings. Accordingly, the article has been retracted.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 재료 | pcl
|
폴리카프로락톤 | dict | 4 | |
| 재료 | polycaprolactone
|
폴리카프로락톤 | dict | 3 | |
| 시술 | dermal filler
|
필러 주입술 | dict | 2 | |
| 시술 | filler
|
필러 주입술 | dict | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- Choroidal ischemia after self-injection of hyaluronic acid filler.
- Intra-articular therapies for synovial joint dysfunction: a comprehensive integrative review.
- Clinical safety of a low-modification hyaluronic acid filler (MoD 2%) for facial rejuvenation.
- A Fibrous-Porous Microsphere-Based Composite Filler for Synchronized Immediate and Long-Term Soft Tissue Restoration.